A5040738709- Mechanical Circulatory Support Devices
- Cardiac Arrest and Resuscitation
- Heart Failure Treatment and Management
- Cardiac Structural Anomalies and Repair
- Family and Patient Care in Intensive Care Units
- Palliative Care and End-of-Life Issues
- Cardiac pacing and defibrillation studies
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Decision-Making and Restraints
- Cardiovascular Function and Risk Factors
- Patient-Provider Communication in Healthcare
- Geriatric Care and Nursing Homes
- Transplantation: Methods and Outcomes
- Health Policy Implementation Science
- Chronic Disease Management Strategies
- Intensive Care Unit Cognitive Disorders
- Healthcare cost, quality, practices
- Cardiac Health and Mental Health
- Health Literacy and Information Accessibility
- Pharmaceutical Practices and Patient Outcomes
- Frailty in Older Adults
- Medication Adherence and Compliance
- Cardiac electrophysiology and arrhythmias
- Diabetes Treatment and Management
- COVID-19 and healthcare impacts
University of Colorado Denver
2016-2025
University of Colorado Anschutz Medical Campus
2016-2025
Outcomes Research Consortium
2015-2024
University of Colorado Health
2023-2024
RELX Group (United States)
2024
University of Colorado System
2016-2024
Children's Hospital Colorado
2023
Denver School of Nursing
2022
Rosenthaler + Partner (Switzerland)
2020
University of Colorado Boulder
2019
Many individuals living with heart failure (HF) rely on unpaid support from their partners, family members, friends, or neighbors as caregivers to help manage chronic disease. Given the advancements in treatments and devices for patients HF, caregiving responsibilities have expanded recent decades include more intensive care increasingly precarious HF-tasks that would previously been undertaken by healthcare professionals clinical settings. The specific tasks of HF vary widely based...
Shared decision making helps patients and clinicians elect therapies aligned with patients' values preferences. This is particularly important for invasive considerable trade-offs.To assess the effectiveness of a shared support intervention considering destination therapy left ventricular assist device (DT LVAD) placement.From 2015 to 2017, randomized, stepped-wedge trial was conducted in 6 US LVAD implanting centers including 248 being considered DT LVAD. After randomly varying time usual...
Major gaps exist in the routine initiation and dose up-titration of guideline-directed medical therapies (GDMT) for patients with heart failure reduced ejection fraction. Without novel approaches to improve prescribing, cumulative benefits fraction treatment will be largely unrealized. Direct-to-consumer marketing shared decision making reflect a culture where are increasingly involved choices, creating opportunities prescribing interventions that engage patients. The EPIC-HF (Electronically...
Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% 50% despite recent scientific advances. Age is a nonmodifiable risk factor for in patients with cardiogenic and often considered the decision-making process eligibility various therapies. Older adults have been largely excluded from analyses therapeutic options shock. As result, association advanced age worse focused strategies assessment management this high-risk growing population are...
For patients and their loved ones, decisions regarding the end of life in setting chronic progressive illness are among most complex health care. Complicating these increasingly available, invasive, potentially life-prolonging technologies such as left ventricular assist device (LVAD).To understand experience bereaved caregivers at who have an LVAD.Semistructured, in-depth interviews were conducted between September 10 November 21, 2014, with 8 LVAD recruited from a single institution. Data...
<h3>Importance</h3> The clinical practice guidelines for heart failure recommend the use of validated risk models to estimate prognosis. Understanding how well identify individuals who will die in next year informs decision making advanced treatments and hospice. <h3>Objective</h3> To quantify calculated routine more than 50% 1-year mortality among ambulatory patients with subsequent year. <h3>Design, Setting, Participants</h3> Ambulatory adults from 3 integrated health systems were enrolled...
Destination therapy left ventricular assist devices (DT LVADs) are one of the most invasive medical interventions for end-stage illness. How patients decide whether or not to proceed with device implantation is unknown. We aimed understand decision-making processes who either accept decline DT LVADs.Between October 2012 and September 2013, we conducted semistructured, in-depth interviews patients' experiences. Data were analyzed using a mixed inductive deductive approach. Twenty-two eligible...
Background— Implanting centers often require the identification of a dedicated caregiver before destination therapy left ventricular assist device (DT LVAD) implantation; however, experience surrounding this difficult decision is relatively unexplored. Methods and Results— From October 2012 through July 2013, we conducted semistructured, in-depth interviews with caregivers patients considering DT LVAD. Data were analyzed using mixed inductive deductive approach. We interviewed 17 caregivers:...
Shared decision making is important to ensure that patients receive therapies aligned with their goals and values. Based upon a detailed needs assessment diverse stakeholders, pamphlet video aids for destination therapy left ventricular assist devices (DT LVAD) were developed help caregivers think through, forecast, deliberate options. These are the foundation of Multicenter Trial Decision Support Intervention Patients Caregivers Offered Destination Therapy End-Stage Heart Failure...